281-296-7300

  • Awards
  • Careers
logo
  • About
    • About VGXI
    • Leadership
    • VGXI Mission
    • Awards
    • Careers
  • Services
    • Manufacturing Services
    • cGMP Plasmid
    • HD Plasmid
    • Pre-Clinical Plasmid
    • Additional Services
  • VGXI Process
    • VGXI Manufacturing Process
    • Analytical Testing
    • Quality Systems
  • Resource Center
    • News
    • Events
    • FAQs
    • Whitepapers
    • Posters & Presentations
  • Contact Us
  • Awards
  • Careers

Recent News

VGXI Official COVID-19 Statement

March 31, 2022

To our Valued Clients and Business Partners, VGXI’s top priority is to continue delivering the highest quality DNA products and services while ensuring the security and safety of our team. VGXI is actively monitoring the evolving situation and will continue to provide updates as new information becomes available. Manufacturing activities have been… Read More »

VGXI to Exhibit at the International HCV Symposium

September 17, 2019

The 26th International Symposium on Hepatitis C Virus and Related Viruses focuses on the advancement of HCV and related virus research, vaccines, and therapies. We welcome you to stop by VGXI’s booth or schedule a meeting with one of our representatives during the conference to learn more about VGXI’s plasmid manufacturing services and experience!… Read More »

VGXI to Exhibit at the Cell & Gene Meeting on the Mesa

September 17, 2019

The Cell & Gene Meeting on the Mesa is a three-day conference bringing together senior executives and top decision-makers in the industry with the scientific community to advance cutting-edge research into cures. Be sure to stop by VGXI’s booth or schedule a meeting with one of our representatives during the conference to learn how VGXI’s… Read More »

Texas Based CMO VGXI and Geneos Therapeutics Establish Supply Agreement for Production of GT-EPIC-Based Personalized Cancer Therapeutics

June 22, 2019

Industry recognized plasmid DNA manufacturer VGXI, Inc. to support production of personalized cancer therapies as part of a long-term supply agreement with Geneos Therapeutics. June 22, 2019, The Woodlands, TX and Plymouth Meeting, PA – Plasmid CMO VGXI, Inc. and Geneos Therapeutics, Inc., a spin-out of Inovio Pharmaceuticals (NASDAQ: INO) focused on developing… Read More »

VGXI Announces Launch of its New Website

May 20, 2019

A new and completely redesigned website offers visitors a comprehensive overview of VGXI’s range of plasmid DNA manufacturing services and capabilities. May 20, 2019, The Woodlands, TX – Texas based CMO VGXI, Inc., which specializes in production of DNA plasmid biopharmaceuticals, announced it has gone live with a refreshed website and online… Read More »

VGXI to Exhibit at the 2019 BIO International Convention

May 6, 2019

With over 16,000 attendees, BIO is one of the largest biotech partnering, education, and networking events in the world. Be sure to stop by VGXI’s Booth #3349 or schedule a meeting with one of our representatives during the conference to learn how VGXI’s plasmid manufacturing services can support your gene or cell therapy program! Contact Us directly… Read More »

VGXI Announces Participation in the 2019 ASGCT Annual Meeting

April 4, 2019

Plasmid CMO VGXI will be speaking at the 22nd Annual ASGCT Meeting in Washington DC. April 04, 2019, The Woodlands, TX – VGXI, Inc., an industry leading plasmid DNA contract manufacturing organization today announced that Mr. Stephen Rodriguez, Sr. Manager, Process Development, will be presenting during the Tools and Technologies Forum of… Read More »

Meet with VGXI at the 2019 ASGCT Meeting

April 3, 2019

The American Society of Gene and Cell Therapy (ASGCT) Annual Meeting provides an international forum where the latest gene and cell therapy developments are presented and critically discussed. Visit VGXI’s Booth #411 or meet with one of our representatives during the conference to learn more about how our plasmid manufacturing services can support your gene or… Read More »

VGXI Announces Continued Progress for RNA Manufacturing Partnership

March 15, 2019

Texas based CMO VGXI Announces Completion of Initial Tech Transfer Milestones as part of its Partnership Agreement for Production of RNA Therapeutics with HMRI. March 15, 2019, The Woodlands, TX – Under a license agreement with the Houston Methodist Research Institute (HMRI) for development of clinical grade RNA manufacturing services, VGXI announced… Read More »

VGXI to Attend the World Vaccine Congress

March 12, 2019

The World Vaccine Congress is a critical strategic partnering event for the global vaccine industry. Visit our Booth #413 or meet with a representative from VGXI during the conference in April to learn more about how our plasmid manufacturing services can support your vaccine program! We welcome meeting requests through the WVC partnering… Read More »

VGXI to Attend Gene Therapy for Rare Disorders

March 11, 2019

Gene Therapy for Rare Disorders focuses exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market. Meet with a representative from VGXI during the conference to learn more about how our plasmid manufacturing services can support your gene therapy products! Contact Us today to schedule a meeting time…. Read More »

Visit VGXI at Phacilitate Leaders World 2019

January 14, 2019

Combined with the World Stem Cell Summit, Phacilitate Leaders World is the worlds largest advanced therapies partnering event. Stop by VGXI’s Booth # 713 to meet with representatives from our company and learn more about our plasmid manufacturing products and services! We welcome meeting requests through the Phacilitate partnering website, or contact Us today to schedule… Read More »

VGXI Celebrates Grand Opening of New Flex-Scale Production Plant for GMP

November 7, 2018

U.S. Congressman Kevin Brady visited Texas-based CMO VGXI to celebrate the grand opening of the company’s new flexible scale GMP production plant for DNA and RNA based therapeutics. VGXI, an industry recognized plasmid DNA contract manufacturing organization, announced the grand opening of a facility expansion which includes flexible scale plasmid DNA manufacturing… Read More »

  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 18
  • Next »

Archives

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • About
  • Services
  • VGXI Process
  • Contact Us
  • Careers
  • Awards
  • Resource Center
logo white

281-296-7300
2700 Research Forest Drive, Suite 180
The Woodlands, Texas 77381, USA

Teko Font
Please enter your name.
Please enter a valid email address.
Sign Up

Thanks for subscribing! Please check your email for further instructions.

Something went wrong. Please check your entries and try again.

© 2021 VGXI, Inc. All Rights Reserved.Terms | Privacy Policy